þ
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
41-1838504
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
1099 Helmo Avenue N, Suite 250
Oakdale, Minnesota
|
|
55128
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Large accelerated filer
o
|
|
Accelerated filer
þ
|
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
o
|
|
PAGE
|
|
|
EX-31.1
|
|
EX-31.2
|
|
EX-32.1
|
|
EX-32.2
|
|
EX-10.1
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Net revenue
|
|
$
|
10.7
|
|
|
$
|
15.7
|
|
Cost of goods sold
|
|
6.3
|
|
|
9.7
|
|
||
Gross profit
|
|
4.4
|
|
|
6.0
|
|
||
Operating expenses:
|
|
|
|
|
||||
Selling, general and administrative
|
|
10.6
|
|
|
16.8
|
|
||
Research and development
|
|
3.4
|
|
|
3.0
|
|
||
Restructuring and other
|
|
6.8
|
|
|
0.6
|
|
||
Total
|
|
20.8
|
|
|
20.4
|
|
||
Operating loss from continuing operations
|
|
(16.4
|
)
|
|
(14.4
|
)
|
||
Other (income) expense:
|
|
|
|
|
||||
Interest income
|
|
—
|
|
|
(0.1
|
)
|
||
Interest expense
|
|
—
|
|
|
0.4
|
|
||
(Income) loss from short term investment
|
|
(1.6
|
)
|
|
—
|
|
||
Other, net expense (income)
|
|
1.5
|
|
|
0.7
|
|
||
Total
|
|
(0.1
|
)
|
|
1.0
|
|
||
Loss from continuing operations before income taxes
|
|
(16.3
|
)
|
|
(15.4
|
)
|
||
Income tax provision (benefit)
|
|
(1.6
|
)
|
|
0.1
|
|
||
Loss from continuing operations
|
|
(14.7
|
)
|
|
(15.5
|
)
|
||
Discontinued operations:
|
|
|
|
|
||||
Gain on sale of discontinued businesses, net of income taxes
|
|
2.4
|
|
|
—
|
|
||
Income (loss) from operations of discontinued businesses, net of income taxes
|
|
(3.1
|
)
|
|
1.1
|
|
||
Reclassification of cumulative translation adjustment
|
|
(75.7
|
)
|
|
—
|
|
||
Income (loss) from discontinued operations, net of income taxes
|
|
(76.4
|
)
|
|
1.1
|
|
||
Net loss
|
|
$
|
(91.1
|
)
|
|
$
|
(14.4
|
)
|
|
|
|
|
|
||||
Loss per common share — basic:
|
|
|
|
|
||||
Continuing operations
|
|
$
|
(0.40
|
)
|
|
$
|
(0.38
|
)
|
Discontinued operations
|
|
(2.06
|
)
|
|
0.03
|
|
||
Net loss
|
|
(2.46
|
)
|
|
(0.35
|
)
|
||
Loss per common share — diluted:
|
|
|
|
|
||||
Continuing operations
|
|
$
|
(0.40
|
)
|
|
$
|
(0.38
|
)
|
Discontinued operations
|
|
(2.06
|
)
|
|
0.03
|
|
||
Net loss
|
|
(2.46
|
)
|
|
(0.35
|
)
|
||
|
|
|
|
|
||||
Weighted average shares outstanding — basic:
|
|
37.1
|
|
|
41.0
|
|
||
Weighted average shares outstanding — diluted:
|
|
37.1
|
|
|
41.0
|
|
||
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Net loss
|
|
$
|
(91.1
|
)
|
|
$
|
(14.4
|
)
|
|
|
|
|
|
||||
Other comprehensive (loss) income, net of tax:
|
|
|
|
|
||||
|
|
|
|
|
||||
Net unrealized gains (losses) on derivative financial instruments:
|
|
|
|
|
||||
Net holding gains (losses) arising during the period
|
|
—
|
|
|
0.9
|
|
||
Reclassification adjustment for net realized gains recorded in net loss
|
|
—
|
|
|
(2.1
|
)
|
||
Total net unrealized gains (losses) on derivative financial instruments
|
|
—
|
|
|
(1.2
|
)
|
||
|
|
|
|
|
||||
Net pension adjustments:
|
|
|
|
|
||||
Liability adjustments for defined benefit plans
|
|
0.1
|
|
|
—
|
|
||
Reclassification adjustment for defined benefit plans recorded in net loss
|
|
1.3
|
|
|
0.2
|
|
||
Total net pension adjustments
|
|
1.4
|
|
|
0.2
|
|
||
|
|
|
|
|
||||
Net foreign currency translation:
|
|
|
|
|
||||
Unrealized foreign currency translation gains (losses)
|
|
(0.8
|
)
|
|
(4.6
|
)
|
||
Reclassification of cumulative translation adjustments
|
|
75.7
|
|
|
—
|
|
||
Total net foreign currency translation
|
|
74.9
|
|
|
(4.6
|
)
|
||
|
|
|
|
|
||||
Total other comprehensive income (loss), net of tax
|
|
76.3
|
|
|
(5.6
|
)
|
||
|
|
|
|
|
||||
Comprehensive loss
|
|
$
|
(14.8
|
)
|
|
$
|
(20.0
|
)
|
|
|
March 31,
|
|
December 31,
|
||||
|
|
2016
|
|
2015
|
||||
Assets
|
|
|
|
|
||||
Current assets:
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
26.2
|
|
|
$
|
70.4
|
|
Short term investments
|
|
36.8
|
|
|
—
|
|
||
Accounts receivable, net
|
|
6.6
|
|
|
9.8
|
|
||
Inventories
|
|
6.5
|
|
|
8.1
|
|
||
Other current assets
|
|
4.4
|
|
|
19.1
|
|
||
Current assets of discontinued operations
|
|
22.0
|
|
|
44.3
|
|
||
Total current assets
|
|
102.5
|
|
|
151.7
|
|
||
Property, plant and equipment, net
|
|
3.5
|
|
|
4.2
|
|
||
Intangible assets, net
|
|
4.0
|
|
|
4.2
|
|
||
Goodwill
|
|
3.8
|
|
|
3.8
|
|
||
Other assets
|
|
0.8
|
|
|
0.8
|
|
||
Non-current assets of discontinued operations
|
|
$
|
3.1
|
|
|
$
|
3.7
|
|
Total assets
|
|
$
|
117.7
|
|
|
$
|
168.4
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
|
||||
Current liabilities:
|
|
|
|
|
||||
Accounts payable
|
|
$
|
7.1
|
|
|
$
|
5.0
|
|
Short-term debt
|
|
—
|
|
|
—
|
|
||
Other current liabilities
|
|
18.1
|
|
|
30.5
|
|
||
Current liabilities of discontinued operations
|
|
49.2
|
|
|
74.6
|
|
||
Total current liabilities
|
|
74.4
|
|
|
110.1
|
|
||
Other liabilities
|
|
28.9
|
|
|
27.0
|
|
||
Other liabilities of discontinued operations
|
|
4.7
|
|
|
6.9
|
|
||
Total liabilities
|
|
108.0
|
|
|
144.0
|
|
||
Commitments and contingencies (Note 15)
|
|
|
|
|
|
|
||
Shareholders’ equity:
|
|
|
|
|
||||
Preferred stock, $.01 par value, authorized 25 million shares, none issued and outstanding
|
|
—
|
|
|
—
|
|
||
Common stock, $.01 par value, authorized 100 million shares, 42.9 million issued
|
|
0.4
|
|
|
0.4
|
|
||
Additional paid-in capital
|
|
1,042.2
|
|
|
1,042.0
|
|
||
Retained deficit
|
|
(985.0
|
)
|
|
(893.9
|
)
|
||
Accumulated other comprehensive loss
|
|
(19.8
|
)
|
|
(96.1
|
)
|
||
Treasury stock, at cost
|
|
(28.1
|
)
|
|
(28.0
|
)
|
||
Total shareholders' equity
|
|
9.7
|
|
|
24.4
|
|
||
Total liabilities and shareholders’ equity
|
|
$
|
117.7
|
|
|
$
|
168.4
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Cash Flows from Operating Activities:
|
|
|
|
|
||||
Net loss
|
|
$
|
(91.1
|
)
|
|
$
|
(14.4
|
)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
||||
Depreciation and amortization
|
|
0.7
|
|
|
5.4
|
|
||
Reclassification cumulative translation adjustment
|
|
75.7
|
|
|
—
|
|
||
Short term investment
|
|
(36.6
|
)
|
|
—
|
|
||
Other, net
|
|
1.3
|
|
|
2.7
|
|
||
Changes in operating assets and liabilities
|
|
(19.5
|
)
|
|
(9.2
|
)
|
||
Net cash used in operating activities
|
|
(69.5
|
)
|
|
(15.5
|
)
|
||
Cash Flows from Investing Activities:
|
|
|
|
|
||||
Capital expenditures
|
|
(0.1
|
)
|
|
(0.8
|
)
|
||
Proceeds from sale of business
|
|
4.7
|
|
|
—
|
|
||
Proceeds from sale of assets
|
|
20.8
|
|
|
0.4
|
|
||
Net cash provided by (used in) investing activities
|
|
25.4
|
|
|
(0.4
|
)
|
||
Cash Flows from Financing Activities:
|
|
|
|
|
||||
Purchase of treasury stock
|
|
—
|
|
|
(0.7
|
)
|
||
Short-term debt repayment
|
|
(0.2
|
)
|
|
(6.4
|
)
|
||
Short-term borrowings
|
|
—
|
|
|
7.4
|
|
||
Net cash (used in) provided by financing activities
|
|
(0.2
|
)
|
|
0.3
|
|
||
Effect of exchange rate changes on cash and cash equivalents
|
|
0.1
|
|
|
(2.8
|
)
|
||
Net change in cash and cash equivalents
|
|
(44.2
|
)
|
|
(18.4
|
)
|
||
Cash and cash equivalents — beginning of period
|
|
70.4
|
|
|
114.6
|
|
||
Cash and cash equivalents — end of period
|
|
$
|
26.2
|
|
|
$
|
96.2
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(In millions, except for per share amounts)
|
|
2016
|
|
2015
|
||||
Numerator:
|
|
|
|
|
||||
Loss from continuing operations
|
|
$
|
(14.7
|
)
|
|
$
|
(15.5
|
)
|
Income (loss) from discontinued operations
|
|
(76.4
|
)
|
|
1.1
|
|
||
Net loss
|
|
$
|
(91.1
|
)
|
|
$
|
(14.4
|
)
|
Denominator:
|
|
|
|
|
||||
Weighted average number of common shares outstanding during the period - basic
|
|
37.1
|
|
|
41.0
|
|
||
Dilutive effect of stock-based compensation plans
|
|
—
|
|
|
—
|
|
||
Weighted average number of diluted shares outstanding during the period - diluted
|
|
37.1
|
|
|
41.0
|
|
||
|
|
|
|
|
||||
Loss per common share — basic:
|
|
|
|
|
||||
Continuing operations
|
|
$
|
(0.40
|
)
|
|
$
|
(0.38
|
)
|
Discontinued operations
|
|
(2.06
|
)
|
|
0.03
|
|
||
Net loss
|
|
(2.46
|
)
|
|
(0.35
|
)
|
||
Loss per common share — diluted:
|
|
|
|
|
||||
Continuing operations
|
|
$
|
(0.40
|
)
|
|
$
|
(0.38
|
)
|
Discontinued operations
|
|
(2.06
|
)
|
|
0.03
|
|
||
Net loss
|
|
(2.46
|
)
|
|
(0.35
|
)
|
||
|
|
|
|
|
||||
Anti-dilutive shares excluded from calculation
|
|
5.1
|
|
|
4.4
|
|
|
|
Three Months Ended
|
|||||
|
|
March 31,
|
|||||
(In millions)
|
|
2016
|
|
2015
|
|||
Net revenue
|
|
2.0
|
|
|
$
|
139.7
|
|
Cost of goods sold
|
|
0.6
|
|
|
111.7
|
|
|
Gross Profit
|
|
1.4
|
|
|
28.0
|
|
|
Selling, General and administrative
|
|
4.0
|
|
|
24.2
|
|
|
Research and development
|
|
0.5
|
|
|
1.8
|
|
|
Restructuring and other
|
|
(0.3
|
)
|
|
0.6
|
|
|
Reclassification of cumulative translation adjustment
|
|
75.7
|
|
|
—
|
|
|
Other (Income) Expense
|
|
0.3
|
|
|
0.3
|
|
|
Income (loss) from operations of discontinued businesses, before income taxes
|
|
(78.8
|
)
|
|
1.1
|
|
|
Gain on sale of discontinued businesses, before income taxes
|
|
3.8
|
|
|
—
|
|
|
Income tax provision
|
|
1.4
|
|
|
—
|
|
|
Income (loss) from discontinued operations, net of income taxes
|
|
(76.4
|
)
|
|
$
|
1.1
|
|
|
|
March 31,
|
|
December 31,
|
||||
(In millions)
|
|
2016
|
|
2015
|
||||
Accounts Receivable:
|
|
|
|
|
||||
Accounts receivable
|
|
$
|
7.2
|
|
|
$
|
10.4
|
|
Less reserves and allowances
(1)
|
|
(0.6
|
)
|
|
(0.6
|
)
|
||
Accounts receivable, net
|
|
$
|
6.6
|
|
|
$
|
9.8
|
|
Inventories:
|
|
|
|
|
||||
Finished goods
|
|
$
|
0.1
|
|
|
$
|
0.9
|
|
Raw materials and supplies
|
|
6.4
|
|
|
7.2
|
|
||
Total inventories
|
|
$
|
6.5
|
|
|
$
|
8.1
|
|
Property, Plant and Equipment:
|
|
|
|
|
||||
Property, plant and equipment
|
|
$
|
12.7
|
|
|
$
|
12.7
|
|
Less accumulated depreciation
|
|
(9.2
|
)
|
|
(8.5
|
)
|
||
Property, plant and equipment, net
|
|
$
|
3.5
|
|
|
$
|
4.2
|
|
(In millions)
|
|
Developed Technology
|
|
Total
|
||||
March 31, 2016
|
|
|
|
|
||||
Cost
|
|
$
|
4.3
|
|
|
$
|
4.3
|
|
Accumulated amortization
|
|
(0.3
|
)
|
|
(0.3
|
)
|
||
Intangible assets, net
|
|
$
|
4.0
|
|
|
$
|
4.0
|
|
December 31, 2015
|
|
|
|
|
||||
Cost
|
|
$
|
4.3
|
|
|
$
|
4.3
|
|
Accumulated amortization
|
|
(0.1
|
)
|
|
(0.1
|
)
|
||
Intangible assets, net
|
|
$
|
4.2
|
|
|
$
|
4.2
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(In millions)
|
|
2016
|
|
2015
|
||||
Amortization expense
|
|
$
|
0.2
|
|
|
$
|
1.9
|
|
(In millions)
|
|
2016
(Remainder) |
|
2017
|
|
2018
|
|
2019
|
|
2020
|
||||||||||
Amortization expense
|
|
$
|
0.5
|
|
|
$
|
0.7
|
|
|
$
|
0.7
|
|
|
$
|
0.7
|
|
|
$
|
0.7
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(In millions)
|
|
2016
|
|
2015
|
||||
Restructuring Expense:
|
|
|
|
|
||||
Severance and related
|
|
$
|
—
|
|
|
$
|
0.1
|
|
Total restructuring
|
|
$
|
—
|
|
|
$
|
0.1
|
|
Other Expense:
|
|
|
|
|
||||
Pension settlement/curtailment (Note 9)
|
|
1.2
|
|
|
—
|
|
||
Asset disposals / write down
|
|
0.3
|
|
|
—
|
|
||
Other
(1)
|
|
5.3
|
|
|
0.5
|
|
||
Total
|
|
$
|
6.8
|
|
|
$
|
0.6
|
|
(In millions)
|
|
Severance and Related
|
|
Lease Termination Costs
|
|
Other
|
|
Total
|
||||
Accrued balance at December 31, 2015
|
|
1.0
|
|
|
—
|
|
|
—
|
|
|
1.0
|
|
Usage and payments
|
|
(0.6
|
)
|
|
—
|
|
|
—
|
|
|
(0.6
|
)
|
Accrued balance at March 31, 2016
|
|
0.4
|
|
|
—
|
|
|
—
|
|
|
0.4
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(In millions)
|
|
2016
|
|
2015
|
||||
Stock-based compensation expense
|
|
$
|
0.2
|
|
|
$
|
0.9
|
|
|
|
Stock Options
|
|
Weighted Average Exercise Price
|
|||
Outstanding December 31, 2015
|
|
4,551,221
|
|
|
$
|
9.02
|
|
Granted
|
|
20,000
|
|
|
0.83
|
|
|
Exercised
|
|
—
|
|
|
—
|
|
|
Canceled
|
|
(437,920
|
)
|
|
17.06
|
|
|
Forfeited
|
|
(264,207
|
)
|
|
1.46
|
|
|
Outstanding March 31, 2016
|
|
3,869,094
|
|
|
$
|
8.59
|
|
Exercisable as of March 31, 2016
|
|
2,867,618
|
|
|
$
|
11.06
|
|
|
Three Months Ended
|
||||
|
March 31,
|
||||
|
2016
|
|
2015
|
||
Volatility
|
41.0
|
%
|
|
46.0
|
%
|
Risk-free interest rate
|
1.8
|
%
|
|
1.9
|
%
|
Expected life (months)
|
72
|
|
|
73
|
|
Dividend yield
|
—
|
|
|
—
|
|
|
|
Restricted Stock
|
|
Weighted Average Grant Date Fair Value Per Share
|
|||
Nonvested as of December 31, 2015
|
|
1,162,776
|
|
|
$
|
2.34
|
|
Granted
|
|
—
|
|
|
—
|
|
|
Vested
|
|
(155,596
|
)
|
|
2.62
|
|
|
Forfeited
|
|
(67,615
|
)
|
|
2.88
|
|
|
Nonvested as of March 31, 2016
|
|
939,565
|
|
|
$
|
2.26
|
|
|
|
United States
|
|
International
|
||||||||||||
|
|
Three Months Ended March 31,
|
||||||||||||||
(In millions)
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Service cost
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
0.1
|
|
Interest cost
|
|
0.7
|
|
|
0.7
|
|
|
—
|
|
|
0.1
|
|
||||
Expected return on plan assets
|
|
(0.9
|
)
|
|
(1.0
|
)
|
|
—
|
|
|
(0.2
|
)
|
||||
Amortization of net actuarial loss
|
|
0.1
|
|
|
0.3
|
|
|
—
|
|
|
0.1
|
|
||||
Amortization of prior service credit
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Net periodic pension (credit) cost
|
|
$
|
(0.1
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
0.1
|
|
Settlement loss
|
|
1.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Curtailment gain
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total pension (credit) cost
|
|
$
|
1.1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
0.1
|
|
|
March 31, 2016
|
Quoted Prices in Active Markets for Identical Assets
(Level 1)
|
Significant Other Observable Inputs
(Level 2)
|
Unobservable Inputs
(Level 3)
|
||||
Assets:
|
|
|
|
|
||||
Trading securities
|
36.8
|
|
0.2
|
|
36.6
|
|
—
|
|
Liabilities:
|
|
|
|
|
||||
Contingent consideration associated with CDI acquisition
|
0.8
|
|
—
|
|
|
0.8
|
|
|
|
|
|
|
|
||||
|
December 31, 2015
|
Quoted Prices in Active Markets for Identical Assets
(Level 1)
|
Significant Other Observable Inputs
(Level 2)
|
Unobservable Inputs
(Level 3)
|
||||
Assets:
|
|
|
|
|
||||
Trading securities
|
1.0
|
|
1.0
|
|
—
|
|
—
|
|
Warrants
|
0.4
|
|
—
|
|
—
|
|
0.4
|
|
Liabilities:
|
|
|
|
|
||||
Contingent consideration associated with CDI acquisition
|
0.8
|
|
—
|
|
—
|
|
0.8
|
|
|
|
Treasury Shares
|
|
Balance as of December 31, 2015
|
|
7,159,474
|
|
Purchases
|
|
—
|
|
Exercise of stock options
|
|
—
|
|
Restricted stock grants
|
|
101,155
|
|
Forfeitures and other
|
|
—
|
|
Balance as of March 31, 2016
|
|
7,260,629
|
|
(In millions)
|
|
Gains (Losses) on Derivative Financial Instruments
|
|
Defined Benefit Plans
|
|
Foreign Currency Translation
|
|
Total
|
||||||||
Balance as of December 31, 2015
|
|
$
|
—
|
|
|
$
|
(20.1
|
)
|
|
$
|
(76.0
|
)
|
|
$
|
(96.1
|
)
|
Other comprehensive income (loss) before reclassifications, net of tax
|
|
—
|
|
|
0.1
|
|
|
(0.8
|
)
|
|
(0.7
|
)
|
||||
Amounts reclassified from accumulated other comprehensive income (loss), net of tax
|
|
—
|
|
|
1.3
|
|
|
75.7
|
|
|
77.0
|
|
||||
Net current period other comprehensive (loss) income
|
|
—
|
|
|
1.4
|
|
|
74.9
|
|
|
76.3
|
|
||||
Balance as of March 31, 2016
|
|
$
|
—
|
|
|
$
|
(18.7
|
)
|
|
$
|
(1.1
|
)
|
|
$
|
(19.8
|
)
|
|
|
Amounts Reclassified from Accumulated Other Comprehensive Loss
|
Affected Line Item in the Consolidated Statement of Operations Where (Gain) Loss is Presented
|
|||||
|
|
Three Months Ended March 31,
|
|
|||||
(In millions)
|
|
2016
|
|
2015
|
|
|||
Gains on cash flow hedges
|
|
—
|
|
|
(3.2
|
)
|
|
Cost of goods sold
|
Income tax expense
|
|
—
|
|
|
1.1
|
|
|
Income tax provision
|
Subtotal
|
|
—
|
|
|
(2.1
|
)
|
|
|
Amortization of net actuarial loss
|
|
—
|
|
|
0.3
|
|
|
Selling, general and administrative
|
Pension curtailment / settlement loss
|
|
1.8
|
|
|
—
|
|
|
Restructuring and other
|
Income tax expense
|
|
(0.5
|
)
|
|
(0.1
|
)
|
|
Income tax provision
|
Subtotal
|
|
1.3
|
|
|
0.2
|
|
|
|
Cumulative translation adjustments
|
|
75.7
|
|
|
—
|
|
|
Discontinued operations
|
Income tax benefit
|
|
—
|
|
|
—
|
|
|
Income tax provision
|
Subtotal
|
|
75.7
|
|
|
—
|
|
|
|
Total reclassifications for the period
|
|
77.0
|
|
|
(1.9
|
)
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(In millions)
|
|
2016
|
|
2015
|
||||
Net revenue
|
|
|
|
|
||||
Nexsan
|
|
10.7
|
|
|
15.7
|
|
||
Total net revenue
|
|
$
|
10.7
|
|
|
$
|
15.7
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(In millions)
|
|
2016
|
|
2015
|
||||
Operating income (loss) from continuing operations
|
|
|
|
|
||||
Nexsan
|
|
(5.2
|
)
|
|
(7.2
|
)
|
||
Total segment operating loss
|
|
(5.2
|
)
|
|
(7.2
|
)
|
||
Corporate and unallocated
|
|
(4.4
|
)
|
|
(6.6
|
)
|
||
Restructuring and other
|
|
(6.8
|
)
|
|
(0.6
|
)
|
||
Total operating loss
|
|
(16.4
|
)
|
|
(14.4
|
)
|
||
Interest income
|
|
—
|
|
|
(0.1
|
)
|
||
Interest expense
|
|
—
|
|
|
0.4
|
|
||
Short term investment (income) loss
|
|
(1.6
|
)
|
|
—
|
|
||
Other, net expense
|
|
1.5
|
|
|
0.7
|
|
||
Loss from continuing operations before income taxes
|
|
$
|
(16.3
|
)
|
|
$
|
(15.4
|
)
|
•
|
Net revenue from continuing operations (Nexsan) of
$10.7 million
for the three months ended
March 31, 2016
was down
31.8 percent
compared with
$15.7 million
in the same period last year. The decrease was a result of the planned reductions in unprofitable regions and low margin transactions. Foreign currency exchange rate impact was immaterial for the three months ended
March 31, 2016
.
|
•
|
Operating loss from continuing operations was
$16.4 million
for the three months ended
March 31, 2016
compared with an operating loss of
$14.4 million
in the same period last year. The operating loss for the three months ended March 31, 2016 includes charges of $
6.8 million
for restructuring and other, mostly related to the restructuring program approved in September, 2015. As we have substantially completed the legacy business wind-down, we do not expect a significant restructuring cost going forward.
|
•
|
Diluted loss per share from continuing operations was
$0.40
for the three months ended
March 31, 2016
compared with a diluted loss per share of
$0.38
for the same period last year.
|
•
|
Cash and cash equivalents totaled
$26.2 million
at
March 31, 2016
compared with
$70.4 million
at
December 31, 2015
. The decline in the cash balance of $44.2 million was primarily due to investing the excess cash of $35.0 million into Clinton Lighthouse Equity Strategies Fund, operating loss and payment of restructuring related costs, offset by the proceeds from sales of assets.
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Percent Change
|
|||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||||||
Net revenue
|
|
$
|
10.7
|
|
|
$
|
15.7
|
|
|
(31.8
|
)%
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Percent Change
|
|||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||||||
Gross profit
|
|
$
|
4.4
|
|
|
$
|
6.0
|
|
|
(26.7
|
)%
|
Gross margin
|
|
41.1
|
%
|
|
38.2
|
%
|
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Percent Change
|
|||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||||||
Selling, general and administrative
|
|
$
|
10.6
|
|
|
$
|
16.8
|
|
|
(36.9
|
)%
|
As a percent of revenue
|
|
99.1
|
%
|
|
107.0
|
%
|
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Percent Change
|
|||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||||||
Research and development
|
|
$
|
3.4
|
|
|
$
|
3.0
|
|
|
13.3
|
%
|
As a percent of revenue
|
|
31.8
|
%
|
|
19.1
|
%
|
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Percent Change
|
|||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||||||
Restructuring and other
|
|
$
|
6.8
|
|
|
$
|
0.6
|
|
|
1,033.3
|
%
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Percent Change
|
|||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||||||
Operating loss from continuing operations
|
|
$
|
(16.4
|
)
|
|
$
|
(14.4
|
)
|
|
13.9
|
%
|
As a percent of revenue
|
|
(153.3
|
)%
|
|
(91.7
|
)%
|
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Percent Change
|
|||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||||||
Interest income
|
|
$
|
—
|
|
|
$
|
(0.1
|
)
|
|
NM
|
|
Interest expense
|
|
—
|
|
|
0.4
|
|
|
NM
|
|
||
(Income) loss from short term investment
|
|
(1.6
|
)
|
|
—
|
|
|
NM
|
|
||
Other, net expense (income)
|
|
1.5
|
|
|
0.7
|
|
|
114.3
|
%
|
||
Total other expense
|
|
$
|
(0.1
|
)
|
|
$
|
1.0
|
|
|
(110.0
|
)%
|
As a percent of revenue
|
|
(0.9
|
)%
|
|
6.4
|
%
|
|
|
|
|
Three Months Ended
|
|
|
||||||
|
|
March 31,
|
|
Percent Change
|
||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
|||||
Income tax provision (benefit)
|
|
$
|
(1.6
|
)
|
|
$
|
0.1
|
|
|
NM
|
Effective tax rate
|
|
9.8
|
%
|
|
(0.6
|
)%
|
|
|
|
|
Three Months Ended
|
|
||||
|
|
March 31,
|
|
||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||
Net revenue
|
|
2.0
|
|
|
139.7
|
|
|
Cost of goods sold
|
|
0.6
|
|
|
111.7
|
|
|
Gross profit
|
|
1.4
|
|
|
28.0
|
|
|
Selling, general and administrative
|
|
4.0
|
|
|
24.2
|
|
|
Research and development
|
|
0.5
|
|
|
1.8
|
|
|
Restructuring and other
|
|
(0.3
|
)
|
|
0.6
|
|
|
Reclassification of cumulative translation adjustment
|
|
75.7
|
|
|
—
|
|
|
Other (income) expense
|
|
0.3
|
|
|
0.3
|
|
|
Income (loss) from operations of discontinued businesses, before income taxes
|
|
(78.8
|
)
|
|
1.1
|
|
|
Gain on sale of discontinued businesses, before income taxes
|
|
3.8
|
|
|
—
|
|
|
Income tax provision
|
|
1.4
|
|
|
—
|
|
|
Income (loss) from discontinued operations, net of income taxes
|
|
(76.4
|
)
|
|
1.1
|
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Percent Change
|
|||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||||||
Net revenue
|
|
$
|
10.7
|
|
|
$
|
15.7
|
|
|
(31.8
|
)%
|
Operating income (loss)
|
|
(5.2
|
)
|
|
(7.2
|
)
|
|
(27.8
|
)%
|
||
As a percent of revenue
|
|
(48.6
|
)%
|
|
(45.9
|
)%
|
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Percent Change
|
|||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
|
||||||
Operating loss
|
|
$
|
(4.4
|
)
|
|
$
|
(6.6
|
)
|
|
(33.3
|
)%
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
||||
Net loss
|
|
$
|
(91.1
|
)
|
|
$
|
(14.4
|
)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
||||
Depreciation and amortization
|
|
0.7
|
|
|
5.4
|
|
||
Reclassification of cumulative translation adjustment
|
|
75.7
|
|
|
—
|
|
||
Short term investment
|
|
(36.6
|
)
|
|
—
|
|
||
Other, net
|
|
1.3
|
|
|
2.7
|
|
||
Changes in operating assets and liabilities
|
|
(19.5
|
)
|
|
(9.2
|
)
|
||
Net cash used in operating activities
|
|
$
|
(69.5
|
)
|
|
$
|
(15.5
|
)
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
||||
Capital expenditures
|
|
$
|
(0.1
|
)
|
|
$
|
(0.8
|
)
|
Proceeds from sale of business
|
|
4.7
|
|
|
—
|
|
||
Proceeds from sale of assets
|
|
20.8
|
|
|
0.4
|
|
||
Net cash used in investing activities
|
|
$
|
25.4
|
|
|
$
|
(0.4
|
)
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(Dollars in millions)
|
|
2016
|
|
2015
|
||||
Purchase of treasury shares
|
|
$
|
—
|
|
|
$
|
(0.7
|
)
|
Exercise of stock options
|
|
—
|
|
|
—
|
|
||
Short-term debt repayment
|
|
(0.2
|
)
|
|
(6.4
|
)
|
||
Short-term borrowings
|
|
—
|
|
|
7.4
|
|
||
Net cash used in financing activities
|
|
$
|
(0.2
|
)
|
|
$
|
0.3
|
|
Exhibit Number
|
|
Description of Exhibit
|
31.1
|
|
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2
|
|
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32.1
|
|
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
32.2
|
|
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
10.1
|
|
Amended and Restated Letter Agreement, dated April 29, 2016, by and between Imation Corp. and Clinton Group, Inc.
|
101
|
|
The following financial information from Imation Corp.’s Quarterly Report on Form 10-Q for the period ended March 31, 2016, formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Operations for the three months ended March 31, 2016 and 2015, (ii) the Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2016 and 2015, (iii) the Condensed Consolidated Balance Sheets as of March 31, 2016 and December 31, 2015, (iv) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2016 and 2015, and (v) the Notes to Condensed Consolidated Financial Statements.
|
|
|
|
Imation Corp.
|
Date:
|
May 12, 2016
|
|
/s/ Danny Zheng
|
|
|
|
Danny Zheng
|
|
|
|
Vice President and Chief Financial Officer
(duly authorized officer and principal financial officer)
|
Exhibit Number
|
|
Description of Exhibit
|
31.1
|
|
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2
|
|
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32.1
|
|
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
32.2
|
|
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
10.1
|
|
Amended and Restated Letter Agreement, dated April 29, 2016, by and between Imation Corp. and Clinton Group, Inc.
|
101
|
|
The following financial information from Imation Corp.’s Quarterly Report on Form 10-Q for the period ended March 31, 2016, formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Operations for the three months ended March 31, 2016 and 2015, (ii) the Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2016 and 2015, (iii) the Condensed Consolidated Balance Sheets as of March 31, 2016 and December 31, 2015, (iv) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2016 and 2015, and (v) the Notes to Condensed Consolidated Financial Statements.
|
1.
|
Incentive Fee
. At the end of each fiscal quarter, the Investment Manager shall be entitled to an incentive fee (the "Incentive Fee") equal to 25% of the increase in the NAV of each series of Class A Shares held by the Investor (adjusted proportionately for distributions and redemptions of Shares) above the higher of the NAV of such series at the date (i) at which each such series was issued and (ii) the date immediately following the date that an Incentive Fee was last paid in respect of such series (such highest NAV per Share for the Investor with respect to a fiscal quarter being called its "Prior High NAV"). The Incentive Fee will also be paid other than at the end of the fiscal quarter with respect to a partial or complete redemption of the Investor's Shares and upon the winding-up and liquidation of the Fund. The Prior High NAV shall be proportionately adjusted to account for redemptions by the Investor in a series of Shares.
|
2.
|
Management Fee
. The Investment Manager hereby agrees to waive the Management Fee with respect to the Investor.
|
3.
|
Confidentiality
.
|
(a)
|
Except as permitted pursuant to this Section 3, each party hereto agrees that it shall not, directly or indirectly, at any time communicate, reveal, disclose or divulge to any third party the existence of this Agreement or any of the specific terms of this Agreement (the "Confidential Material").
|
(b)
|
Notwithstanding Section 3(a), each party may disclose the Confidential Material to its affiliates, legal counsel, financial advisors, accountants, service providers and similar representatives, and their respective affiliates, directors, officers, or employees (collectively, "Disclosure Representatives");
provided,
that such Disclosure Representatives have been informed of the confidential nature of the Confidential Material and are subject to confidentiality obligations substantially similar to the confidentiality obligations set forth in the Fund Documents. Each party shall be responsible for the breach of this Section 3 by any of its Disclosure Representatives
|
(c)
|
Notwithstanding Section 3(a), the Investment Manager may, on a redacted basis, disclose this Agreement to its investors and potential investors.
|
(d)
|
Notwithstanding Section 3(a), each party may disclose the Confidential Material (i) upon the prior written consent of the other party, (ii) if the Confidential Material is otherwise publicly available other than by reason of any default under this Agreement or as a result of the other party's breach of its confidentiality obligations under a confidentiality agreement, or other contractual, legal or fiduciary obligation of confidentiality with respect to the Confidential Material, (iii) to reduce or eliminate withholding or other taxes, (iv) to the extent requested by any regulatory authority purporting to have jurisdiction over a party, including any self regulatory authority, (v) to a court of competent jurisdiction, or (vi) if the release thereof is required by any applicable law;
provided
, that, in the case of clauses (iv), (v) and (vi), the disclosing party shall use commercially reasonable efforts to provide timely advance written notice to the other party of such disclosure. The parties agree that this Agreement shall qualify as written consent to the disclosure of Confidential Material that is required in any routine regulatory filing or document required to be prepared by law.
|
(e)
|
Notwithstanding anything herein to the contrary, each party (and each employee, representative or other agent of such party) may disclose to any persons, without limitation of any kind, the tax treatment and tax structure of the Fund, its transactions and transactions contemplated hereby and all materials of any kind (including opinions or other tax analyses) that are provided to such party relating to such tax treatment and tax structure. For this purpose, "tax structure" does not include information relating to the identity of the parties.
|
4.
|
Committee Approval
. So long as the Investor is a shareholder of the Fund, the parties hereto agree that the Committee shall meet at least once a month to evaluate Imation Corp's investment in the Fund.
|
5.
|
Effectiveness.
This Agreement supersedes, where applicable, and supplements the terms and provisions of the Fund Documents. In the event of any inconsistency between the terms of the Fund Documents and the terms of this Agreement, the terms of this Agreement shall control.
|
6.
|
Governing Law.
This Agreement shall be construed and interpreted under the laws of the State of Delaware, without giving effect to any conflict of law principles thereunder.
|
7.
|
No Assignment
. No assignment by the Investors of all or any portion of their rights, obligations or liabilities under this Agreement shall be permitted without the prior written consent of the Investment Manager.
|
8.
|
Amendments
. No amendment to, or alteration of the terms of, this Agreement shall be valid unless made in writing and signed by all of the parties thereto. The Investor will be notified of any material changes to the fund documents including changes to the management and performance fees outlined in the funds offering documents.
|
9.
|
Counterparts
. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same document, and may be executed by facsimile signature, which shall have the same force and effect as the original.
|
•
|
2/12/16 Subscription Date
|
•
|
3/24/16 Subscription Date
|
•
|
4/14/16 Subscription Date
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Imation Corp.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a -15(e) and 15d -15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
May 12, 2016
|
|
|
|
|
|
By:
|
/s/ ROBERT B. FERNANDER
|
|
|
Robert B. Fernander,
|
|
|
Interim Chief Executive Officer
|
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Imation Corp.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a -15(e) and 15d -15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
May 12, 2016
|
|
|
|
|
|
By:
|
/s/ DANNY ZHENG
|
|
|
Danny Zheng,
|
|
|
Vice President and Chief Financial Officer
|
|
|
|
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
May 12, 2016
|
|
|
|
/s/ ROBERT B. FERNANDER
|
|
Robert B. Fernander,
|
|
Interim Chief Executive Officer
|
|
|
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
May 12, 2016
|
|
|
|
/s/ DANNY ZHENG
|
|
Danny Zheng,
|
|
Vice President and Chief Financial Officer
|
|